Prasugrel (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Prasugrel drug offered from Aurobindo Pharma Limited. This Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
NON-PROPRIETARY NAME: | Prasugrel |
SUBSTANCE NAME: | PRASUGREL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-16 |
END MARKETING DATE: | 0000-00-00 |
Prasugrel HUMAN PRESCRIPTION DRUG Details:
Item Description | Prasugrel from Aurobindo Pharma Limited |
LABELER NAME: | Aurobindo Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-10-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65862-829_596c923d-db8d-4b96-bf31-52186a38c30d |
PRODUCT NDC: | 65862-829 |
APPLICATION NUMBER: | ANDA205888 |
Other PRASUGREL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: